8th Circ. Revives Class Action Over KV Recalls

By Jocelyn Allison · January 19, 2011, 3:56 PM EST

The Eighth Circuit on Wednesday revived a class action against KV Pharmaceutical Co. over its recalls of hypertension drug metoprolol succinate ER, finding that the plaintiffs' claims are not preempted by...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Recent Articles By Jocelyn

February 22, 2019
Tracing Puerto Rico's Journey Through Bankruptcy
November 09, 2016
After Trump's Triumph, What's Next?
January 21, 2011
United, Merck Hit With Navy Communications IP Suits
January 19, 2011
FDA Unveils Changes To Medical Device Review Process
January 18, 2011
Weil Advises Advent In $1.5B Buy Of Priory From RBS
January 13, 2011
Ex-Home Diagnostics CEO Charged With Insider Trading
January 04, 2011
FDA Tackles Food Safety As Funding Remains Uncertain
December 16, 2010
Elan, Eisai To Pay $214M Over Zonegran Marketing
December 15, 2010
FDA Warns Of Hidden Ingredients In Supplements
December 14, 2010
Judge OKs $27M Deal In Cooper Securities Action